Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Kunik, M. E. Articles by Stanley, M. A. Search for Related Content PubMed Citation Articles by Kunik, M. E. Articles by Stanley, M. A. Primary Care Anxiety Disorders (General) Depression Syndromes Secondary to General Medical Disorders Tests

A Practical Screening Tool for Anxiety and Depression in Patients With Chronic Breathing Disorders

From the Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, the Michael E. DeBakey Veterans Affairs Medical Center; the Menninger Dept. of Psychiatry and Behavioral Sciences, Dept. of Medicine, Baylor College of Medicine; and the Veteran Affairs South Central Mental Illness Research, Education, and Clinical Center. Send correspondence and reprint requests to Mark E. Kunik, M.D., M.P.H., Houston Center for Quality of Care and Utilization Studies, Michael E DeBakey VAMC (152), 2002 Holcombe, Houston, TX 77030. e-mail: mkunik{at}bcm.tmc.edu

Obstructive lung diseases are associated with high rates of depression and anxiety, yet many patients are never screened or treated. This study evaluated the five-question Depression and Anxiety modules of the Primary Care Evaluation of Mental Disorders (PRIME-MD) Patient Questionnaire as a telephone screen in 1,632 patients with chronic breathing disorders at a Veterans Affairs Medical Center in Houston, TX. Subsequent testing of 828 patients with the Beck Depression Inventory–II and the Beck Anxiety Inventory showed that the sensitivity and specificity, respectively, of the Depression and Anxiety modules of the PRIME-MD Patient Questionnaire screening were 94.6% and 49.5% (Depression); 93.7% and 32.2% (Anxiety); and 97.7%, and 36.0% (combined screen), with an overall accuracy of 80.7%. In such populations, these two modules of the PRIME-MD Patient Questionnaire may be a useful screening tool.

This article has been cited by other articles:

				K. Hill, R. Geist, R. S. Goldstein, and Y. Lacasse Anxiety and depression in end-stage COPD Eur. Respir. J., March 1, 2008; 31(3): 667 - 677. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us